Topic: Drug Discovery & Development January 11, 2024 Awardees announced for Needleman innovation, commercialization programDeSelm, DiPersio, Lavine receive support to advance promising therapeutics in cancer, heart disease.Medical Campus & Community October 18, 2023 Biotech industry leader to helm WashU drug development acceleratorBhagwat leads program aimed at moving promising therapeutics into clinical trials .News Release August 4, 2023 Podcast: Newly approved drug may slow progression of Alzheimer’sThis episode of 'Show Me the Science' focuses on approval of a drug that attacks a key protein that contributes to dementia from Alzheimer’s disease.Podcast, Show Me the Science May 5, 2023 Needleman innovation program seeks proposals for therapeutic developmentUp to $4 million in funding available to pursue ‘investigational new drug’ status.Medical Campus & Community May 3, 2023 Discovery suggests route to safer pain medicationsTargeting opioid receptor pathway could treat pain without addiction, hallucinations.News Release February 9, 2023 Needlemans commit $15 million to boost drug discoveryGift from longtime WashU benefactors to advance promising drug targets into early clinical trials .News Release November 30, 2022 WashU, pharmacy scientists alter fentanyl, aim to make it less lethal, less addictiveGoal is to reduce dangerous side effects of potent opioid pain reliever.News Release September 7, 2022 Nasal COVID-19 vaccine approved in India based on Washington University technologyInhaled vaccine may reduce infection, transmission.News Release November 18, 2021 Podcast: What’s up with boosters?This episode of 'Show Me the Science' discusses the expanding availability of booster vaccines in the fight against COVID-19.Podcast, Show Me the Science November 11, 2021 Living with COVID-19Science, medicine and healthcare adapt to a pandemic world.Outlook Magazine November 3, 2021 Podcast: Vaccines approved for younger kidsThis episode of 'Show Me the Science' focuses on the newly announced federal emergency use authorization to vaccinate children ages 5 to 11. Millions of such children could be fully vaccinated by November's end.Podcast, Show Me the Science October 28, 2021 Inventive pathways: A research powerhouse becomes an innovation incubatorTurning research discoveries into real-world solutions can mean a decade of challenges. WashU is working to clear the way.Outlook Magazine October 11, 2021 Antiviral compound blocks SARS-CoV-2 from entering cellsNew compound also could be effective against other coronaviruses.News Release July 8, 2021 New Alzheimer’s treatment targets identifiedStudy points to FDA-approved drugs that have potential to slow or reverse brain damage.News Release May 20, 2021 Cheng honored for work to advance pain relief without adverse effectsAnesthesiologist receives award from International Anesthesia Research Society.National Leaders March 11, 2021 Combating COVID-19: Labs pivot to fight a common enemyLabs retooled to investigate how the virus causes disease and to develop drugs, vaccines and diagnostics.Outlook Magazine March 7, 2021 Finding a possible early treatment for COVID-19 in a 40-year-old antidepressantSource: CBS News/60 Minutes December 29, 2020 Podcast: Vaccines have arrived but COVID-19 treatments progressing much more slowlyThis episode of 'Show Me the Science' contrasts the rapid development of effective vaccines with the lack of progress toward effective therapies.Podcast, Show Me the Science December 9, 2020 Podcast: COVID-19 vaccines around the cornerThis episode of 'Show Me the Science' reports on progress toward a vaccine and how to stay safe before vaccines become widely available.Podcast, Show Me the Science December 1, 2020 Gene that protects against osteoarthritis identifiedIn mouse study, loss of molecule contributes to disease while surplus reduces symptoms.News Release November 12, 2020 Fluvoxamine may prevent serious illness in COVID-19 patientsAntidepressant drug repurposed for patients with coronavirus infection.News Release April 13, 2020 Podcast: Clinical trials launch to evaluate antimalarial, antidepressant drugs to treat COVID-19Repurposing of FDA-approved drugs is fastest way to launch COVID-19 clinical trials.Podcast, Show Me the Science April 13, 2020 Study to evaluate antidepressant as potential COVID-19 treatmentDrug fluvoxamine may help prevent life-threatening ‘cytokine storm’.News Release February 26, 2020 Revving up immune system may help treat eczemaBoosting natural killer cells in mice improves skin rash.News Release, Video Posts navigation 1 2 3 4 Next ›